Immunohistochemical expression of p53, p63, c-myc, p21WAF1/cip1 and p27kiP1 proteins in urothelial bladder carcinoma: correlation with clinicopathological parameters

被引:0
作者
Grapsa, Dimitra [1 ]
Dokou, Anna [1 ]
Tsokanou-Kouli, Vassiliki [2 ]
Kaltsas, Serafim [1 ]
Dalakou, Eleftheria [1 ]
Trigidou, Rodoula [3 ]
Saif, Muhammad W. [4 ]
Politi, Ekaterini [2 ]
机构
[1] Sotiria Gen Hosp, Athens Sch Med, Dept Med 3, Oncol Unit, Athens 11527, Greece
[2] Arete Hosp, Dept Cytopathol, Athens, Greece
[3] Sotiria Gen Hosp, Dept Pathol, Athens 11527, Greece
[4] Tufts Med Ctr, Div Hematol Oncol, Boston, MA USA
来源
JOURNAL OF BUON | 2014年 / 19卷 / 04期
关键词
c-myc; cyclin-dependent kinase inhibitors; p53; p63; urinary bladder carcinoma; CANCER; PROGRESSION; BIOMARKERS; P21; PRB;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To reevaluate the expression levels of p53, p63, c-myc, p21(WAF1/cip1) and p27(kiP1) proteins and their potential association with standard clinicopathological parameters, including tumor stage and grade, in urothelial bladder carcinoma (UBC). Methods: Immunohistochemistry was performed in 100 transurethral resection specimens obtained from prospectively identified patients with primary UBC. Results: Overall, 26, 41 and 75% of the cases showed positive staining for p53, p63 and c-myc, respectively, while p21(WAF1/cip1) and p27(kip1) expression levels were altered in 75 and 88% of the cases, respectively. Positive staining for p53 was associated with increased tumor stage (pT2) (p=0.037), while altered expression of p27(kiP1) was strongly associated with male gender (p=0.009). Conclusion: The results of our study imply that p53 overexpression may be a useful marker of tumor invasion in UBC. In contrast, we failed to demonstrate any statistically significant correlation between the remaining markers evaluated and tumor stage or grade.
引用
收藏
页码:1121 / 1124
页数:4
相关论文
共 12 条
[1]  
Baffa R, 2006, J EXP CLIN CANC RES, V25, P145
[2]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[3]   Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma [J].
Chatterjee, SJ ;
Datar, R ;
Youssefzadeh, D ;
George, B ;
Goebell, PJ ;
Stein, JP ;
Young, LL ;
Shi, SR ;
Gee, C ;
Groshen, S ;
Skinner, DG ;
Cote, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1007-1013
[4]   Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma.: A tissue microarray study of 158 cases [J].
Compérat, E ;
Camparo, P ;
Haus, R ;
Chartier-Kastler, E ;
Bart, S ;
Delcourt, A ;
Houlgatte, A ;
François, R ;
Capron, F ;
Vieillefond, A .
VIRCHOWS ARCHIV, 2006, 448 (03) :319-324
[5]   Immunohistochemical biomarkers for bladder cancer prognosis [J].
Matsushita, Kazuhito ;
Cha, Eugene K. ;
Matsumoto, Kazumasa ;
Baba, Shiro ;
Chromecki, Thomas F. ;
Fajkovic, Harun ;
Sun, Maxine ;
Karakiewicz, Pierre I. ;
Scherr, Douglas S. ;
Shariat, Shahrokh F. .
INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (09) :616-629
[6]   Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? [J].
Netto, George J. .
NATURE REVIEWS UROLOGY, 2012, 9 (01) :41-51
[7]   Predictive value of molecular alterations for the prognosis of urothelial carcinoma [J].
Schulz, WA ;
Jankevicius, F ;
Gerharz, CD ;
Kushima, M ;
van Roeyen, C ;
Bultel, H ;
Gobell, P ;
Schmitz-Drager, BJ .
CANCER DETECTION AND PREVENTION, 1998, 22 (05) :422-429
[8]   p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer [J].
Shariat, SF ;
Tokunaga, H ;
Zhou, J ;
Kim, J ;
Ayala, GE ;
Benedict, WF ;
Lerner, SP .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1014-1024
[9]   Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy [J].
Shariat, Shahrokh F. ;
Karakiewicz, Pierre I. ;
Ashfaq, Raheela ;
Lerner, Seth P. ;
Palapattu, Ganesh S. ;
Cote, Richard J. ;
Sagalowsky, Arthur I. ;
Lotan, Yair .
CANCER, 2008, 112 (02) :315-325
[10]   Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness [J].
Shariat, Shahrokh F. ;
Zlotta, Alexandre R. ;
Ashfaq, Raheela ;
Sagalowsky, Arthur I. ;
Lotan, Yair .
MODERN PATHOLOGY, 2007, 20 (04) :445-459